Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1998-3-30
pubmed:abstractText
This study evaluated the effects of combining antibiotic therapy with the application of a nonsteroidal anti-inflammatory drug on the degradation of articular cartilage for an animal model of Staphylococcal septic arthritis. Rabbits were infected intra-articularly with Staphylococcus aureus. Antibiotic treatment started 18 hours after infection and continued for 7 days. Treatment with the nonsteroidal anti-inflammatory drug naproxen sodium started 24 hours before infection and continued for either 3 or 7 weeks. The cartilage matrix of uninfected and infected knees was quantified by analysis of glycosaminoglycan and collagen content. Three weeks after infection, the combined treatment of the nonsteroidal anti-inflammatory drug and antibiotics reduced the loss of glycosaminoglycan and collagen from the cartilage of the infected knee by 15 and 30%, respectively, compared with antibiotic treatment alone. Continuing treatment with naproxen sodium for 7 weeks reduced the loss of collagen by 50% when compared with antibiotic treatment alone. The longer period of treatment with naproxen sodium showed little further effect on the loss of glycosaminoglycan than that observed for the 3-week treatment. Treatment with this drug and antibiotics reduced swelling of the knee and levels of prostaglandin E2 in the synovial fluid. The data support the hypothesis that decreasing post-infectious inflammation by adding the drug to a standard antibiotic regimen reduces cartilage damage from Staphylococcal septic arthritis.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0736-0266
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
919-26
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9497819-Animals, pubmed-meshheading:9497819-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:9497819-Arthritis, Infectious, pubmed-meshheading:9497819-Cartilage, Articular, pubmed-meshheading:9497819-Ceftriaxone, pubmed-meshheading:9497819-Cephalosporins, pubmed-meshheading:9497819-Dinoprostone, pubmed-meshheading:9497819-Disease Models, Animal, pubmed-meshheading:9497819-Drug Therapy, Combination, pubmed-meshheading:9497819-Female, pubmed-meshheading:9497819-Glycosaminoglycans, pubmed-meshheading:9497819-Hydroxyproline, pubmed-meshheading:9497819-Knee Joint, pubmed-meshheading:9497819-Naproxen, pubmed-meshheading:9497819-Rabbits, pubmed-meshheading:9497819-Staphylococcal Infections, pubmed-meshheading:9497819-Staphylococcus aureus, pubmed-meshheading:9497819-Synovial Fluid, pubmed-meshheading:9497819-Synovitis
pubmed:year
1997
pubmed:articleTitle
Staphylococcal septic arthritis: antibiotic and nonsteroidal anti-inflammatory drug treatment in a rabbit model.
pubmed:affiliation
Orthopaedic Research Laboratory, Stanford University Medical Center, CA 94305-5341, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't